Categories AlphaGraphs, Earnings, Industrials
Earnings: Boeing shares rise on upbeat fourth-quarter results
Airplane maker Boeing (BA) posted its fourth-quarter 2018 results before the bell on Wednesday, Jan. 30. Shares jumped in pre-market trade following the announcement of both upbeat top-line and bottom-line results.
Revenues soared 14% to $28.34 billion, generating an 8% hike in quarterly EPS to $5.93 per share. GAAP net earnings inched 3% to $3.42 billion.
CEO Dennis Muilenburg weighed in, “our financial performance provided a firm platform to further invest in new growth businesses, innovation and future franchise programs, as well as in our people and enabling technologies. In the last 5 years, we have invested nearly $35 billion in key strategic areas of our business, all while increasing cash returns to shareholders.”
JUST IN: ALIBABA Q3 2019 EARNINGS!
Commercial Airplanes Deliveries rose 14% to 238 in the quarter. Cash and investments in marketable securities totaled $8.6 billion, and the debt was $13.8 billion at quarter-end.
During the quarter, Boeing delivered 238 Commercial Airplanes, including its first 737 MAX Boeing Business Jet.
OUTLOOK: LOOKING TO 2019
The Boeing Company announced a new outlook for fiscal 2019. Revenue for the year is expected to be $109.5-111.5 billion, generating GAAP earnings of $21.90-22.10 per share. Core earnings per share is touted to be $19.90-20.10. Annual operating cash flow is estimated at $17.0-17.5 billion.
Boeing expects to deliver a record 895-905 commercial airplanes, generating revenues of $64.5-65.5 billion in 2019.
We’re on Flipboard! Follow us to receive the latest stock market, earnings, and financial news at your fingertips
Most Popular
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company
Walgreens Boots Alliance set to report earnings next week. Here’s what to expect
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with
Comments